Zimmer Biomet Holdings Income After Taxes 2010-2024 | ZBH
Zimmer Biomet Holdings annual/quarterly income after taxes history and growth rate from 2010 to 2024. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
- Zimmer Biomet Holdings income after taxes for the quarter ending March 31, 2024 was $0.173B, a 25.74% decline year-over-year.
- Zimmer Biomet Holdings income after taxes for the twelve months ending March 31, 2024 was $0.965B, a 114.16% increase year-over-year.
- Zimmer Biomet Holdings annual income after taxes for 2023 was $1.025B, a 252.03% increase from 2022.
- Zimmer Biomet Holdings annual income after taxes for 2022 was $0.291B, a 34.64% decline from 2021.
- Zimmer Biomet Holdings annual income after taxes for 2021 was $0.446B, a 4942.39% decline from 2020.
| Zimmer Biomet Holdings Annual Income After Taxes (Millions of US $) |
|
|---|---|
| 2023 | $1,025 |
| 2022 | $291 |
| 2021 | $446 |
| 2020 | $-9 |
| 2019 | $1,132 |
| 2018 | $-379 |
| 2017 | $1,813 |
| 2016 | $305 |
| 2015 | $146 |
| 2014 | $719 |
| 2013 | $779 |
| 2012 | $753 |
| 2011 | $760 |
| 2010 | $597 |
| 2009 | $717 |
| Zimmer Biomet Holdings Quarterly Income After Taxes (Millions of US $) |
|
|---|---|
| 2024-03-31 | $173 |
| 2023-12-31 | $420 |
| 2023-09-30 | $163 |
| 2023-06-30 | $210 |
| 2023-03-31 | $233 |
| 2022-12-31 | $-130 |
| 2022-09-30 | $194 |
| 2022-06-30 | $154 |
| 2022-03-31 | $73 |
| 2021-12-31 | $-55 |
| 2021-09-30 | $162 |
| 2021-06-30 | $145 |
| 2021-03-31 | $193 |
| 2020-12-31 | $462 |
| 2020-09-30 | $246 |
| 2020-06-30 | $-208 |
| 2020-03-31 | $-509 |
| 2019-12-31 | $321 |
| 2019-09-30 | $432 |
| 2019-06-30 | $132 |
| 2019-03-31 | $246 |
| 2018-12-31 | $-903 |
| 2018-09-30 | $162 |
| 2018-06-30 | $185 |
| 2018-03-31 | $176 |
| 2017-12-31 | $1,231 |
| 2017-09-30 | $99 |
| 2017-06-30 | $184 |
| 2017-03-31 | $299 |
| 2016-12-31 | $70 |
| 2016-09-30 | $158 |
| 2016-06-30 | $-32 |
| 2016-03-31 | $109 |
| 2015-12-31 | $127 |
| 2015-09-30 | $22 |
| 2015-06-30 | $-174 |
| 2015-03-31 | $171 |
| 2014-12-31 | $149 |
| 2014-09-30 | $173 |
| 2014-06-30 | $176 |
| 2014-03-31 | $221 |
| 2013-12-31 | $255 |
| 2013-09-30 | $154 |
| 2013-06-30 | $152 |
| 2013-03-31 | $218 |
| 2012-12-31 | $152 |
| 2012-09-30 | $178 |
| 2012-06-30 | $214 |
| 2012-03-31 | $209 |
| 2011-12-31 | $156 |
| 2011-09-30 | $191 |
| 2011-06-30 | $204 |
| 2011-03-31 | $209 |
| 2010-12-31 | $35 |
| 2010-09-30 | $191 |
| 2010-06-30 | $166 |
| 2010-03-31 | $205 |
| 2009-12-31 | $155 |
| 2009-09-30 | $150 |
| 2009-06-30 | $210 |
| 2009-03-31 | $202 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $24.724B | $7.394B |
| Zimmer Biomet is a leading musculoskeletal healthcare company that designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $181.078B | 23.71 |
| Stryker (SYK) | United States | $127.496B | 30.54 |
| Medtronic (MDT) | Ireland | $114.087B | 16.15 |
| Boston Scientific (BSX) | United States | $109.519B | 34.88 |
| EssilorLuxottica (ESLOY) | France | $102.905B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $43.259B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.858B | 28.37 |
| ResMed (RMD) | United States | $32.110B | 30.15 |
| Koninklijke Philips (PHG) | Netherlands | $25.984B | 20.13 |
| Terumo (TRUMY) | Japan | $25.953B | 36.65 |
| Baxter (BAX) | United States | $17.963B | 12.77 |
| Insulet (PODD) | United States | $13.116B | 58.16 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.406B | 0.00 |
| Demant (WILYY) | Denmark | $10.234B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.382B | 27.41 |
| BellRing Brands (BRBR) | United States | $7.488B | 35.22 |
| Lantheus Holdings (LNTH) | United States | $5.522B | 13.76 |
| Haemonetics (HAE) | United States | $4.862B | 24.05 |
| GN Store Nord (GNNDY) | Denmark | $4.400B | 24.71 |
| Perrigo (PRGO) | Ireland | $4.066B | 12.33 |
| Prestige Consumer Healthcare (PBH) | United States | $3.227B | 15.36 |
| Envista Holdings (NVST) | United States | $3.185B | 13.14 |
| Neogen (NEOG) | United States | $2.933B | 28.21 |
| QuidelOrtho (QDEL) | United States | $2.868B | 15.92 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.846B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $2.735B | 54.17 |
| TG Therapeutics (TGTX) | United States | $2.547B | 71.65 |
| ICU Medical (ICUI) | United States | $2.534B | 22.36 |
| Agios Pharmaceuticals (AGIO) | United States | $1.950B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.790B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.761B | 51.61 |
| Warby Parker (WRBY) | United States | $1.639B | 0.00 |
| InMode (INMD) | Israel | $1.550B | 8.24 |
| Owens & Minor (OMI) | United States | $1.424B | 12.41 |
| AdaptHealth (AHCO) | United States | $1.329B | 9.88 |
| National Vision Holdings (EYE) | United States | $1.240B | 39.45 |
| AtriCure (ATRC) | United States | $1.101B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.011B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.913B | 0.00 |
| Evolus (EOLS) | United States | $0.851B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.747B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.745B | 15.86 |
| Quanterix (QTRX) | United States | $0.664B | 0.00 |
| Valneva SE (VALN) | France | $0.618B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.612B | 14.39 |
| PetIQ (PETQ) | United States | $0.588B | 19.20 |
| TerrAscend (TSNDF) | Canada | $0.519B | 0.00 |
| Surmodics (SRDX) | United States | $0.494B | 30.91 |
| Jin Medical (ZJYL) | China | $0.465B | 0.00 |
| ZimVie (ZIMV) | United States | $0.464B | 39.58 |
| Aurora Cannabis (ACB) | Canada | $0.403B | 0.00 |
| Cerus (CERS) | United States | $0.364B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.364B | 11.71 |
| Biote (BTMD) | United States | $0.357B | 8.21 |
| Zynex (ZYXI) | United States | $0.346B | 47.30 |
| Viemed Healthcare (VMD) | United States | $0.276B | 27.35 |
| MacroGenics (MGNX) | United States | $0.273B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.264B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.263B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.246B | 15.49 |
| Organigram Holdings (OGI) | Canada | $0.209B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.209B | 0.00 |
| Omeros (OMER) | United States | $0.200B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.197B | 0.00 |
| Veru (VERU) | United States | $0.193B | 0.00 |
| High Tide (HITI) | Canada | $0.175B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.171B | 82.00 |
| InterCure (INCR) | Israel | $0.150B | 25.31 |
| Jushi Holdings (JUSHF) | United States | $0.138B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.134B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.128B | 18.14 |
| Cellectar Biosciences (CLRB) | United States | $0.118B | 0.00 |
| Fonar (FONR) | United States | $0.096B | 8.28 |
| MariMed (MRMD) | United States | $0.094B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.093B | 0.00 |
| Brainsway (BWAY) | Israel | $0.090B | 0.00 |
| Chimerix (CMRX) | United States | $0.089B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.085B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.076B | 0.00 |
| Safety Shot (SHOT) | United States | $0.072B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.062B | 4.03 |
| Apyx Medical (APYX) | United States | $0.055B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.054B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.053B | 0.00 |
| Bright Green (BGXX) | United States | $0.044B | 0.00 |
| United-Guardian (UG) | United States | $0.043B | 15.45 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| ImmuCell (ICCC) | United States | $0.038B | 0.00 |
| Exagen (XGN) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.025B | 0.00 |
| Agape ATP (ATPC) | $0.020B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.019B | 0.00 |
| Flora Growth (FLGC) | United States | $0.017B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.014B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.011B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Sharps Technology (STSS) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.003B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |